Today: 3 July 2026
Browse Category

Stock Market 13 January 2026

Vistra stock in focus as VST prices $2.25 billion notes; analysts cite Meta nuclear deal

Vistra stock in focus as VST prices $2.25 billion notes; analysts cite Meta nuclear deal

New York, Jan 13, 2026, 15:24 — Regular session Shares of Vistra Corp nudged up 0.2% to $172.95 on Tuesday, following the announcement that the power producer priced $2.25 billion in senior secured notes. The move aims to back its planned acquisition of Cogentrix. Vistra's stock fluctuated between $170.85 and $177.76 during the session. The newly issued notes, maturing in 2031 and 2036, carry interest rates of 4.700% and 5.350%, respectively, with a closing date set for Jan. 22, according to the company.
13 January 2026
··
1 … 769 770 771 772 773 … 1,613

Stock Market Today

  • AbbVie Jumps 4%, Tops Apogee Buy Price After Earnings Beat
    July 2, 2026, 7:16 PM EDT. AbbVie Inc. finished up 3.99% at $261.07, a new 52-week high. The stock gained nearly $17.8 billion in market cap, putting it well above the $10.9 billion Apogee Therapeutics deal announced June 22. AbbVie closed above targets from RBC Capital, Investing.com and Google Finance. With Q2 earnings set for July 31, the rally puts the spotlight on analyst target hikes. J.P. Morgan and RBC Capital have backed the Apogee buy for its long-term growth, with the company saying the acquisition will add to EPS by 2032. AbbVie outpaced broader markets, which slipped slightly, as investors bet on the drugmaker's deal strategy.
Go toTop